These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38423024)
1. Effect of screening for Neisseria gonorrhoeae and Chlamydia trachomatis on incidence of these infections in men who have sex with men and transgender women taking HIV pre-exposure prophylaxis (the Gonoscreen study): results from a randomised, multicentre, controlled trial. Vanbaelen T; Tsoumanis A; Florence E; Van Dijck C; Huis In 't Veld D; Sauvage AS; Herssens N; De Baetselier I; Rotsaert A; Verhoeven V; Henrard S; Van Herrewege Y; Van den Bossche D; Goffard JC; Padalko E; Reyniers T; Vuylsteke B; Hayette MP; Libois A; Kenyon C Lancet HIV; 2024 Apr; 11(4):e233-e244. PubMed ID: 38423024 [TBL] [Abstract][Full Text] [Related]
2. High incidence of extra-genital gonorrheal and chlamydial infections among high-risk men who have sex with men and transgender women in Peru. Allan-Blitz LT; Konda KA; Calvo GM; Vargas SK; Leon SR; Segura ER; Caceres CF; Klausner JD Int J STD AIDS; 2018 May; 29(6):568-576. PubMed ID: 29183269 [TBL] [Abstract][Full Text] [Related]
3. STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany. Jansen K; Steffen G; Potthoff A; Schuppe AK; Beer D; Jessen H; Scholten S; Spornraft-Ragaller P; Bremer V; Tiemann C; BMC Infect Dis; 2020 Feb; 20(1):110. PubMed ID: 32033533 [TBL] [Abstract][Full Text] [Related]
4. Feasibility and impact of online HIV/STI screening addressed to men who have sex with men and transgender women users of pre-exposure prophylaxis (PrEP) in Spain (TESTATE PrEP): a study protocol for a non-blinded randomised controlled trial. Agustí C; Martínez Riveros H; García-Pérez J; Descalzo V; Fernandez G; Ramírez-Marinero A; Gonzalez MV; Díaz Y; Montoro-Fernandez M; Romano-deGea P; Araujo SG; Muntada E; Casabona J BMJ Open; 2023 Oct; 13(10):e073459. PubMed ID: 37844988 [TBL] [Abstract][Full Text] [Related]
6. Optimizing Screening for Anorectal, Pharyngeal, and Urogenital Chlamydia trachomatis and Neisseria gonorrhoeae Infections in At-Risk Adolescents and Young Adults in New Orleans, Louisiana and Los Angeles, California, United States. Man OM; Ramos WE; Vavala G; Goldbeck C; Ocasio MA; Fournier J; Romero-Espinoza A; Fernandez MI; Swendeman D; Lee SJ; Comulada S; Rotheram-Borus MJ; Klausner JD Clin Infect Dis; 2021 Nov; 73(9):e3201-e3209. PubMed ID: 33300564 [TBL] [Abstract][Full Text] [Related]
7. HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019. Streeck H; Jansen K; Crowell TA; Esber A; Jessen HK; Cordes C; Scholten S; Schneeweiss S; Brockmeyer N; Spinner CD; Bickel M; Esser S; Hartikainen J; Stoehr A; Lehmann C; Marcus U; Vehreschild JJ; Knorr A; Brillen AL; Tiemann C; Robb ML; Michael NL Euro Surveill; 2022 Apr; 27(14):. PubMed ID: 35393933 [TBL] [Abstract][Full Text] [Related]
8. Patterns of Chlamydia trachomatis and Neisseria gonorrhoeae in different anatomical sites among Pre-Exposure Prophylaxis (PrEP) users in Brazil. Antonini M; Vettore MV; Øgård-Repål A; de Macêdo Rocha D; de Alencar Rocha KA; Elias HC; Barufaldi F; Santana RC; Gir E; Spire B; Reis RK BMC Infect Dis; 2024 Feb; 24(1):260. PubMed ID: 38408940 [TBL] [Abstract][Full Text] [Related]
9. Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial. Mayer KH; Molina JM; Thompson MA; Anderson PL; Mounzer KC; De Wet JJ; DeJesus E; Jessen H; Grant RM; Ruane PJ; Wong P; Ebrahimi R; Zhong L; Mathias A; Callebaut C; Collins SE; Das M; McCallister S; Brainard DM; Brinson C; Clarke A; Coll P; Post FA; Hare CB Lancet; 2020 Jul; 396(10246):239-254. PubMed ID: 32711800 [TBL] [Abstract][Full Text] [Related]
10. Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial. Stewart J; Bukusi E; Sesay FA; Oware K; Donnell D; Soge OO; Celum C; Odoyo J; Kwena ZA; Scoville CW; Violette LR; Morrison S; Simoni J; McClelland RS; Barnabas R; Gandhi M; Baeten JM Trials; 2022 Jun; 23(1):495. PubMed ID: 35710444 [TBL] [Abstract][Full Text] [Related]
11. Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study. Kasaie P; Schumacher CM; Jennings JM; Berry SA; Tuddenham SA; Shah MS; Rosenberg ES; Hoover KW; Gift TL; Chesson H; German D; Dowdy DW BMJ Open; 2019 Mar; 9(3):e023453. PubMed ID: 30837248 [TBL] [Abstract][Full Text] [Related]
12. Sexually transmitted infection screening, prevalence and incidence among South African men and transgender women who have sex with men enrolled in a combination HIV prevention cohort study: the Sibanye Methods for Prevention Packages Programme (MP3) project. Jones J; Sanchez TH; Dominguez K; Bekker LG; Phaswana-Mafuya N; Baral SD; McNaghten AD; Kgatitswe LB; Valencia R; Yah CS; Zahn R; Siegler AJ; Sullivan PS J Int AIDS Soc; 2020 Oct; 23 Suppl 6(Suppl 6):e25594. PubMed ID: 33000886 [TBL] [Abstract][Full Text] [Related]
13. Triple site sexually transmitted infection testing as a crucial component of surveillance for men who have sex with men: A prospective cohort study. Zucker R; Gaisa M; Sigel K; Singer I; Adler A; Turner D; Ben Ami R; Nissan I; Chan C; Halperin T Int J STD AIDS; 2022 Feb; 33(2):114-122. PubMed ID: 34676780 [No Abstract] [Full Text] [Related]
14. Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study. Jenness SM; Weiss KM; Goodreau SM; Gift T; Chesson H; Hoover KW; Smith DK; Liu AY; Sullivan PS; Rosenberg ES Clin Infect Dis; 2017 Sep; 65(5):712-718. PubMed ID: 28505240 [TBL] [Abstract][Full Text] [Related]
15. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study. Veloso VG; Cáceres CF; Hoagland B; Moreira RI; Vega-Ramírez H; Konda KA; Leite IC; Bautista-Arredondo S; Vinícius de Lacerda M; Valdez Madruga J; Farias A; Lima JN; Zonta R; Lauria L; Tamayo CVO; Flores HJS; Santa Cruz YMC; Aguayo RMM; Cunha M; Moreira J; Makkeda AR; Díaz S; Guanira JV; Vermandere H; Benedetti M; Ingold HL; Pimenta MC; Torres TS; Grinsztejn B; Lancet HIV; 2023 Feb; 10(2):e84-e96. PubMed ID: 36565708 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of two screening strategies for van Wifferen F; Hoornenborg E; Schim van der Loeff MF; Heijne J; van Hoek AJ Sex Transm Infect; 2021 Dec; 97(8):607-612. PubMed ID: 33431605 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and Correlates of Chlamydia trachomatis and Neisseria gonorrhoeae by Anatomic Site Among Urban Thai Men Who Have Sex With Men. Tongtoyai J; Todd CS; Chonwattana W; Pattanasin S; Chaikummao S; Varangrat A; Lokpichart S; Holtz TH; van Griensven F; Curlin ME Sex Transm Dis; 2015 Aug; 42(8):440-9. PubMed ID: 26165436 [TBL] [Abstract][Full Text] [Related]
18. Vanbaelen T; Kenyon C Sex Transm Infect; 2024 Aug; 100(6):337-338. PubMed ID: 38782583 [No Abstract] [Full Text] [Related]
19. Frequent chlamydia and gonorrhoea but very infrequent syphilis among men who have sex with men using HIV pre-exposure prophylaxis in West Africa. Dah TTE; De Baetselier I; Cuer B; Anoma C; Mensah E; Koné A; Diandé S; Dagnra CA; Faye-Kette HY; Yeo A; Yaya I; Spire B; Keita BD; Crucitti T; Vuylsteke B; Laurent C; Sex Transm Infect; 2024 May; 100(4):201-207. PubMed ID: 38604698 [TBL] [Abstract][Full Text] [Related]